{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:50:16Z","timestamp":1791571816465,"version":"4.3.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T00:00:00Z","timestamp":1590192000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s12094-020-02384-w","type":"journal-article","created":{"date-parts":[[2020,5,23]],"date-time":"2020-05-23T06:02:30Z","timestamp":1590213750000},"page":"172-178","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9732-1094","authenticated-orcid":false,"given":"E.","family":"Lopci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Castello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Saita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N. M.","family":"Buffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Guazzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,23]]},"reference":[{"key":"2384_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","volume":"68","author":"RL Siegel","year":"2018","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"2384_CR2","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/cncr.23575","volume":"113","author":"M Al Otaibi","year":"2008","unstructured":"Al Otaibi M, Ross P, Fahmy N, Jeyaganth S, Trottier H, Sircar K, et al. Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance. Cancer. 2008;113:286\u201392.","journal-title":"Cancer"},{"key":"2384_CR3","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, et al. EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol. 2017;71:618\u201329.","journal-title":"Eur Urol"},{"key":"2384_CR4","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-targeted or standard biopsy for prostate-cancer diagnosis. N Engl J Med. 2018;378:1767\u201377.","journal-title":"N Engl J Med"},{"issue":"1","key":"2384_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","volume":"77","author":"FH Drosy","year":"2020","unstructured":"Drosy FH, Osses D, Nieboer D, et al. Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a cochrane systematic review and meta-analysis. Eur Urol. 2020;77(1):78\u201394.","journal-title":"Eur Urol"},{"key":"2384_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC, et al. Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet. 2017;389:815\u201322.","journal-title":"Lancet"},{"key":"2384_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.eururo.2017.09.015","volume":"73","author":"J Walz","year":"2018","unstructured":"Walz J. The, \u201cPROMIS\u201d of magnetic resonance imaging cost effectiveness in prostate cancer diagnosis? Eur Urol. 2018;73:31\u20132.","journal-title":"Eur Urol"},{"key":"2384_CR8","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.eururo.2018.05.013","volume":"74","author":"G Lughezzani","year":"2018","unstructured":"Lughezzani G, Buffi NM, Lazzeri M. Diagnostic pathway of patients with a clinical suspicion of prostate cancer: does one size fit all? Eur Urol. 2018;74:400\u20131.","journal-title":"Eur Urol"},{"key":"2384_CR9","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1016\/j.ultrasmedbio.2018.02.014","volume":"44","author":"D Rohrbach","year":"2018","unstructured":"Rohrbach D, Wodlinger B, Wen J, Mamou J, Feleppa E. High-frequency quantitative ultrasound for imaging prostate cancer using a novel micro-ultrasound scanner. Ultrasound Med Biol. 2018;44:1341\u201354.","journal-title":"Ultrasound Med Biol"},{"key":"2384_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.juro.2015.12.093","volume":"196","author":"S Ghai","year":"2016","unstructured":"Ghai S, Eure G, Fradet V, Hyndman ME, McGrath T, Wodlinger B, et al. Assessing cancer risk on novel 29 MHz micro-ultrasound images of the prostate: creation of the micro-ultrasound protocol for prostate risk identification. J Urol. 2016;196:562\u20139.","journal-title":"J Urol"},{"key":"2384_CR11","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jamaoncol.2019.0096","volume":"5","author":"WP Fendler","year":"2019","unstructured":"Fendler WP, Calais J, Eiber M, et al. Assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer: a prospective single-arm clinical trial. JAMA Oncol. 2019;5:856\u201363.","journal-title":"JAMA Oncol"},{"key":"2384_CR12","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1007\/s11307-018-1278-8","volume":"21","author":"N Hirmas","year":"2019","unstructured":"Hirmas N, Al-Ibraheem A, Herrmann K, et al. [(68)Ga]PSMA PET\/CT improves initial staging and management plan of patients with high-risk prostate cancer. Mol Imaging Biol. 2019;21:574\u201381.","journal-title":"Mol Imaging Biol"},{"issue":"4","key":"2384_CR13","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2967\/jnumed.115.169243","volume":"57","author":"K Rahbar","year":"2016","unstructured":"Rahbar K, Weckersser M, Huss S, et al. Correlation of intraprostatic tumor extent with 68Ga-PSMA distribution in patients with prostate cancer. J Nucl Med. 2016;57(4):563\u20137.","journal-title":"J Nucl Med"},{"issue":"1","key":"2384_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.juro.2018.01.079","volume":"200","author":"E Lopci","year":"2018","unstructured":"Lopci E, Saita A, Lazzeri M, et al. 68Ga-PSMA positron emission tomography\/computerized tomography for primary diagnosis of prostate cancer in men with contraindications to or negative multiparametric magnetic resonance imaging: a prospective observational study. J Urol. 2018;200(1):95\u2013103.","journal-title":"J Urol"},{"key":"2384_CR15","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.euo.2018.10.001","volume":"2","author":"G Lughezzani","year":"2019","unstructured":"Lughezzani G, Saita A, Lazzeri M, et al. Comparison of the diagnostic accuracy of micro-ultrasound and magnetic resonance imaging\/ultrasound fusion targeted biopsies for the diagnosis of clinically significant prostate cancer. Eur Urol Oncol. 2019;2:329\u201332.","journal-title":"Eur Urol Oncol"},{"key":"2384_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2020.03.004","author":"E Lopci","year":"2020","unstructured":"Lopci E, Lughezzani G, Castello A, et al. Prospective evaluation of 68Ga-PSMA PET\/CT in primary prostate cancer diagnosis. Eur Urol Focus. 2020. https:\/\/doi.org\/10.1016\/j.euf.2020.03.004[Epub ahead of print].","journal-title":"Eur Urol Focus"},{"key":"2384_CR17","doi-asserted-by":"publisher","first-page":"e505","DOI":"10.1016\/S1569-9056(16)60507-9","volume":"15","author":"E Lopci","year":"2016","unstructured":"Lopci E, Lazzeri M, Lughezzani G, et al. Targeted PET\/TRUS software fusion-guided biopsy in men with persistently elevated PSA and negative mpMRI after previous negative biopsy: a feasibility study and preliminary results. Eur Urol Suppl. 2016;15:e505.","journal-title":"Eur Urol Suppl"},{"key":"2384_CR18","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s41824-017-0011-1","volume":"1","author":"M Lazzeri","year":"2017","unstructured":"Lazzeri M, Lopci E, Lughezzani G, et al. Targeted 11C-choline PET-CT\/TRUS software fusion guided prostate biopsy in men with persistently elevated PSA and negative mpMRI or MRI contraindications after previous negative biopsy. Eur J Hybrid Imaging. 2017;1:9.","journal-title":"Eur J Hybrid Imaging"},{"key":"2384_CR19","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1007\/s11548-015-1233-y","volume":"10","author":"O Zetting","year":"2015","unstructured":"Zetting O, Shah A, Hennersperger C, et al. Multimodal image-guided prostate fusion biopsy based on automatic deformable registration. Int J Comput Assist Radiol Surg. 2015;10:1997\u20132007.","journal-title":"Int J Comput Assist Radiol Surg"},{"key":"2384_CR20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016;40:244\u201352.","journal-title":"Am J Surg Pathol"},{"key":"2384_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02848-x","author":"G Ploussard","year":"2019","unstructured":"Ploussard G, Beauval JB, Lesourd M, et al. Performance of systematic, MRI-targeted biopsies alone or in combination for the prediction of unfavourable disease in MRI-positive low-risk prostate cancer patients eligible for active surveillance. World J Urol. 2019. https:\/\/doi.org\/10.1007\/s00345-019-02848-x[Epub ahead of print].","journal-title":"World J Urol"},{"key":"2384_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-019-02863-y","author":"R Abouassaly","year":"2019","unstructured":"Abouassaly R, Klein EA, El-Shefai A, Stephenson A. Impact of using 29 MHz high-resolution micro-ultrasound in real-time targeting of transrectal prostate biopsies: initial experience. World J Urol. 2019. https:\/\/doi.org\/10.1007\/s00345-019-02863-y[Epub ahead of print].","journal-title":"World J Urol"},{"key":"2384_CR23","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3389\/fonc.2019.01368","volume":"9","author":"M Zhang","year":"2019","unstructured":"Zhang M, Wang R, Wu Y, et al. Micro-ultrasound imaging for accuracy of diagnosis in clinically significant prostate cancer: a meta-analysis. Front Oncol. 2019;9:1368.","journal-title":"Front Oncol"},{"key":"2384_CR24","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1007\/s00259-018-4255-1","volume":"46","author":"J Zhang","year":"2019","unstructured":"Zhang J, Shao S, Wu P, et al. Diagnostic performance of 68Ga-PSMA PET\/CT in the detection of prostate cancer prior to initial biopsy: comparison with cancer-predicting nomograms. Eur J Nucl Med Mol Imaging. 2019;46:908\u201320.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2384_CR25","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00259-018-4160-7","volume":"46","author":"P Donato","year":"2019","unstructured":"Donato P, Roberts MJ, Morton A, et al. Improved specificity with 68Ga-PSMA PET\/CT to detect clinically significant lesions \u201cinvisible\u201d on multiparametric MRI of the prostate: a single institution comparative analysis with radical prostatectomy histology. Eur J Nucl Med Mol Imaging. 2019;46:20\u201330.","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02384-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-020-02384-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-020-02384-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,22]],"date-time":"2021-05-22T23:06:33Z","timestamp":1621724793000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-020-02384-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,23]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2384"],"URL":"https:\/\/doi.org\/10.1007\/s12094-020-02384-w","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,23]]},"assertion":[{"value":"1 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"E.L. reports receiving grants from Fondazione AIRC (Associazione Italiana per la Ricerca sul Cancro) and from the Italian Ministry of Health, and faculty remuneration from ESMIT (European School of Multimodality Imaging & Therapy) and MI&T congress. A. Chiti received speaker honoraria from General Electric and Sirtex Medical System, acted as scientific advisor to Blue Earth Diagnostics and Advanced Accelerator Applications, and benefited from an unconditional grant from Sanofi to Humanitas University. All honoraria are outside the scope of the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All legal requirements were met in accomplishing this study (including ethical and radiation protection regulations). All procedures performed in the protocol ICH\/382\/216 protocol involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients have signed the informed consent prior to any investigation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}